Merck Extends Winrevair’s Win Streak With New Mid-Stage Data in Type of Hypertension
Winrevair yielded significant and meaningful clinical benefits for patients with combined post- and precapillary pulmonary hypertension, an indication that, according to BMO Capital Markets, has few treatment options.
Merck Extends Winrevair’s Win Streak With New Mid-Stage Data in Type of Hypertension Read More »
